Related Experiment Videos
[Priapism induced by vasoactive drugs]
1Hospitales Ramón y Cajal y Ruber Internacional, Madrid, España.
Archivos Espanoles De Urologia
|April 1, 1996
Summary
Priapism following intracavernous injections of vasoactive drugs is rare and manageable. Prompt treatment is essential to prevent complications from this uncommon condition.
Area of Science:
- Urology
- Pharmacology
Context:
- Intracavernous injections of vasoactive drugs are used for erectile dysfunction treatment.
- Priapism is a potential complication of these injections.
Purpose:
- To discuss the pathophysiology, diagnosis, and treatment of priapism induced by intracavernous injections.
- To review the incidence and management of postinjection priapism.
Summary:
- Postinjection priapism is an uncommon complication, with an overall incidence below 0.5%.
- Higher incidences (3-12%) have been reported with papaverine monotherapy.
- The condition is generally easily managed with prompt intervention.
Impact:
- Provides a concise overview of postinjection priapism for clinicians.
- Highlights the importance of rapid treatment to minimize sequelae.
- Contributes to the understanding of managing priapism in the context of erectile dysfunction therapies.